Trial
NCT00522548
Myfortic or CellCept Gastrointestinal Effects in African American Kidney Recipients
Phase IVTERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of Pennsylvania
Collaborators
Novartis Pharmaceuticals
Condition
Transplants and Implants
Intervention
Enteric coated mycophenolate sodium
Why stopped
enrollment halted in order to have all patients complete follow-up by Jan 2011
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-01-23